Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $3,325 | 15 | 46.1% |
| Education | $3,055 | 3 | 42.3% |
| Food and Beverage | $835.76 | 45 | 11.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| INTUITIVE SURGICAL, INC. | $6,342 | 18 | $0 (2024) |
| PFIZER INC. | $217.11 | 11 | $0 (2023) |
| AbbVie Inc. | $183.80 | 10 | $0 (2020) |
| Evofem Biosciences, Inc. | $155.89 | 8 | $0 (2024) |
| COLOPLAST CORP | $149.19 | 8 | $0 (2021) |
| Astellas Pharma US Inc | $94.00 | 3 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $33.92 | 2 | $0 (2017) |
| Amgen Inc. | $17.73 | 1 | $0 (2022) |
| Shionogi Inc | $11.66 | 1 | $0 (2017) |
| Medtronic USA, Inc. | $10.46 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,383 | 20 | INTUITIVE SURGICAL, INC. ($6,342) |
| 2023 | $168.40 | 7 | Astellas Pharma US Inc ($94.00) |
| 2022 | $38.45 | 2 | Evofem Biosciences, Inc. ($20.72) |
| 2021 | $141.98 | 7 | PFIZER INC. ($91.50) |
| 2020 | $185.97 | 9 | AbbVie Inc. ($86.93) |
| 2019 | $163.86 | 9 | Coloplast Corp ($69.41) |
| 2018 | $78.54 | 5 | Coloplast Corp ($34.74) |
| 2017 | $56.04 | 4 | Merck Sharp & Dohme Corporation ($33.92) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 3 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/19/2019 | Coloplast Corp | ARIS (Device) | Food and Beverage | Cash or cash equivalent | $20.47 | General |
| Category: FEMALE INCONTINENCE | ||||||
| 06/17/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: Endocrinology | ||||||
| 04/01/2019 | PFIZER INC. | PREMARIN (Drug), ESTRING, COLOGUARD | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: WOMENS HEALTH | ||||||
| 03/18/2019 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Endocrinology | ||||||
| 10/08/2018 | Coloplast Corp | ARIS (Device) | Food and Beverage | Cash or cash equivalent | $16.07 | General |
| Category: FEMALE INCONTINENCE | ||||||
| 10/03/2018 | AbbVie, Inc. | Orilissa (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Endocrinology | ||||||
| 08/23/2018 | PFIZER INC. | PREMARIN (Drug) | Food and Beverage | In-kind items and services | $11.03 | General |
| Category: WOMENS HEALTH | ||||||
| 07/19/2018 | Coloplast Corp | ARIS (Device) | Food and Beverage | Cash or cash equivalent | $18.67 | General |
| Category: FEMALE INCONTINENCE | ||||||
| 07/09/2018 | AbbVie, Inc. | Lupron (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: Endocrinology | ||||||
| 10/16/2017 | Merck Sharp & Dohme Corporation | NUVARING (Drug), NEXPLANON | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: WOMENS HEALTH | ||||||
| 04/12/2017 | Medtronic USA, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $10.46 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 03/20/2017 | Merck Sharp & Dohme Corporation | NUVARING (Drug), NEXPLANON | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: WOMENS HEALTH | ||||||
| 02/13/2017 | Shionogi Inc | Osphena (Drug) | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 4 | 44 | 44 | $15,950 | $4,891 |
| 2020 | 8 | 203 | 236 | $52,480 | $15,209 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 51729 | Complex measurement of pressure of urine flow in bladder (cystometrogram) with bladder canal (urethra) pressure and voiding pressure studies | Office | 2021 | 11 | 11 | $6,600 | $3,036 | 46.0% |
| 51797 | Insertion of device into the abdomen with measurement of pressure and urine flow rate | Office | 2021 | 11 | 11 | $4,400 | $1,517 | 34.5% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2021 | 11 | 11 | $3,300 | $277.86 | 8.4% |
| 51741 | Electronic assessment of bladder emptying | Office | 2021 | 11 | 11 | $1,650 | $60.28 | 3.7% |
| 51729 | Insertion of electronic device into bladder with voiding and bladder canal (urethra) pressure studies | Office | 2020 | 18 | 18 | $10,800 | $4,996 | 46.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 51 | 78 | $9,725 | $3,224 | 33.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 41 | 47 | $7,880 | $2,748 | 34.9% |
| 51797 | Insertion of device into the abdomen with measurement of pressure and urine flow rate | Office | 2020 | 18 | 18 | $7,200 | $2,162 | 30.0% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 21 | 21 | $7,875 | $1,375 | 17.5% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2020 | 18 | 18 | $5,400 | $468.80 | 8.7% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2020 | 18 | 18 | $900.00 | $133.68 | 14.9% |
| 51741 | Electronic assessment of bladder emptying | Office | 2020 | 18 | 18 | $2,700 | $101.44 | 3.8% |
About Dr. Upendra Kulkarni, M.D
Dr. Upendra Kulkarni, M.D is a Obstetrics & Gynecology healthcare provider based in Mamou, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750311478.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Upendra Kulkarni, M.D has received a total of $7,216 in payments from pharmaceutical and medical device companies, with $6,383 received in 2024. These payments were reported across 63 transactions from 10 companies. The most common payment nature is "Travel and Lodging" ($3,325).
As a Medicare-enrolled provider, Kulkarni has provided services to 247 Medicare beneficiaries, totaling 280 services with total Medicare billing of $20,100. Data is available for 2 years (2020–2021), covering 12 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Mamou, LA
- Active Since 07/05/2006
- Last Updated 02/26/2010
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1750311478
Products in Payments
- Da Vinci Surgical System (Device) $3,342
- DAVINCI XI (Device) $3,000
- PREMARIN (Drug) $217.11
- ARIS (Device) $119.12
- Phexxi (Drug) $115.37
- Orilissa (Drug) $79.69
- ORIAHNN (Drug) $66.27
- NUVARING (Drug) $33.92
- Veozah (Drug) $22.13
- ORILISSA (Drug) $20.66
- EVENITY (Biological) $17.73
- Lupron (Drug) $17.18
- FEMALE INCONTINENCE (Device) $17.16
- Myrbetriq (Drug) $16.88
- Aris (Device) $12.91
- Osphena (Drug) $11.66
- INTERSTIM (Device) $10.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.